

Akebia Therapeutics Email Formats
Contact top employees from
Akebia Therapeutics
- Akebia Therapeutics uses 6 different email formats. The most common is firstNamelastName (for example, janedoe@akebia.com), which appears in about 82% of work addresses.
- Other common patterns include:
- lastNameInitial_firstNameInitial: d_j@akebia.com (5%)
- firstName_lastNameInitial: jane_d@akebia.com (9%)
Akebia Therapeutics’s Popular Email Formats
| Format | Example | Percentage |
|---|---|---|
Format firstNamelastName | Percentage: 82% | |
Format firstName_lastNameInitial | Percentage: 9% | |
Format lastNameInitial_firstNameInitial | Percentage: 5% | |
Format firstNameInitial.lastName | Percentage: 2% | |
Format lastNamefirstName | Percentage: 1% | |
Format firstName_lastName | Percentage: 1% |
Contact top employees from
Akebia Therapeutics
Debie Hoivik
Vice President, Early Development
Ron Frieson
Member Board of Directors
Steven Burke
Chief Medical Officer
Sandeepkumar Balabbigari
Medical Communications Manager
Julie Hartung
Key Account Manager
Allison Magwire
Sr Manager, Drug Safety & PV Training and Compliance
Melanie Miller
Key Account Manager
Mary Weidenbach
Vice President Legal
Ralph Capaldi
Sr. Key Account Manager
Jeff Fulop
Key Account Manager
Kelvin Haynes Jr
Key Account Manager
Christine Tierney
Executive Assistant To Chief Executive Officer
Phillip Horton
Vice President, Financial Planning & Analysis
David Glynn
VP Legal, Chief Compliance Officer
Amy Ross
Quality Assurance Stabilty Manager
Nicholas Grund
Chief Commercial Officer (CCO)
Companies Similar to Akebia Therapeutics
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.





